Savella is the third drug to win FDA approval as a fibromyalgia treatment. The first two were Lyrica (pregabalin) and Cymbalta (duloxetine). Savella, an SNRI, is new to the U.S. but has been on the market in several countries as an antidepressant for more than a decade.
Co-Forum Moderator for Chronic Pain
Rare neurodegenerative /movement disorder called “Multiple System Atrophy”. Mobility issues,, neuropathic pain, spasticity, central apnea, collagenous colitis, pain, swallowing and respitory involvement, Implants: intrathecal pump & neurostimulator. Extra features: O2 & wheelchair